Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

4,700

Employees4,700

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

4,700

Employees4,700

MRNA Key Statistics

Market cap

21.22B

Market cap21.22B

Price-Earnings ratio

-7.40

Price-Earnings ratio-7.40

Dividend yield

—

Dividend yield—

Average volume

5.89M

Average volume5.89M

High today

$56.06

High today$56.06

Low today

$52.95

Low today$52.95

Open price

$55.54

Open price$55.54

Volume

13.59M

Volume13.59M

52 Week high

$59.55

52 Week high$59.55

52 Week low

$22.28

52 Week low$22.28

Stock Snapshot

With a market cap of 21.22B, Moderna(MRNA) trades at $53.87. The stock has a price-to-earnings ratio of -7.40.

On 2026-04-18, Moderna(MRNA) stock traded between a low of $52.95 and a high of $56.06. Shares are currently priced at $53.87, which is +1.7% above the low and -3.9% below the high.

Moderna(MRNA) shares are trading with a volume of 13.59M, against a daily average of 5.89M.

In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.

MRNA News

TipRanks 1d

Moderna to present data from Phase 1/2 study of mRNA-4359 at AACR

Moderna (MRNA) announced that the Company will present data from a Phase 1/2 study of mRNA-4359, an investigational cancer antigen therapy, at the American Asso...

Simply Wall St 3d

Assessing Moderna Valuation After Recent Share Price Momentum And Mixed Long Term Returns

Advertisement Recent performance snapshot and why Moderna is on watch With no single headline event driving attention today, Moderna (MRNA) is drawing interes...

Analyst ratings

73%

of 26 ratings

Buy

11.5%

Hold

73.1%

Sell

15.4%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.